Exact Sciences completed the acquisition of PreventionGenetics for $190m.

Exact Sciences, a provider of cancer screening and diagnostic tests, completed the acquisition of PreventionGenetics, a medical laboratory, for $190m. "PreventionGenetics is a natural fit with Exact Sciences, and we're thrilled to have their talented team join in our mission to make earlier cancer detection a routine part of medical care. We share in PreventionGenetics' belief that genetics can transform medicine, improve lives, and help eradicate cancer. With our deep relationships in primary care and PreventionGenetics' strong reputation among genetics specialists, Exact Sciences can help more people understand their inherited risk of cancer to catch it earlier and treat it more effectively," Kevin Conroy, Exact Sciences, Chairman and CEO.